NS-398, a new anti-inflammatory agent, selectively inhibits prostaglandin G/H synthase/cyclooxygenase (COX-2) activity in vitro
- 1 January 1994
- journal article
- Published by Elsevier BV in Prostaglandins
- Vol. 47 (1), 55-59
- https://doi.org/10.1016/0090-6980(94)90074-4
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Selective inhibition of NS-398 on prostanoid production in inflamed tissue in rat carrageenan-air-pouch inflammationJournal of Pharmacy and Pharmacology, 1993
- NS-398, a novel non-steroidal anti-inflammatory drug with potent analgesic and antipyretic effects, which causes minimal stomach lesionsGeneral Pharmacology: The Vascular System, 1993
- Lipopolysaccharide induces prostaglandin H synthase-2 in alveolar macrophagesBiochemical and Biophysical Research Communications, 1992
- Human cyclooxygenase-2 cDNA.Proceedings of the National Academy of Sciences, 1992
- Endogenous glucocorticoids regulate an inducible cyclooxygenase enzyme.Proceedings of the National Academy of Sciences of the United States of America, 1992
- In vivo cyclooxygenase expression in synovial tissues of patients with rheumatoid arthritis and osteoarthritis and rats with adjuvant and streptococcal cell wall arthritis.JCI Insight, 1992
- Mitogen‐inducible prostaglandin G/H synthase: A new target for nonsteroidal antiinflammatory drugsDrug Development Research, 1992
- Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing.Proceedings of the National Academy of Sciences, 1991
- Cloning of human gene encoding prostaglandin endoperoxide synthase and primary structure of the enzymeBiochemical and Biophysical Research Communications, 1989
- Primary structure of prostaglandin G/H synthase from sheep vesicular gland determined from the complementary DNA sequence.Proceedings of the National Academy of Sciences of the United States of America, 1988